Vrenken, H.
212  Ergebnisse:
Personensuche X
?
2

Long-term neuroprotective effects of natalizumab and fingol..:

Noteboom, S. ; Strijbis, E.M.M. ; Coerver, E.M.E....
Multiple Sclerosis and Related Disorders.  87 (2024)  - p. 105670 , 2024
 
?
 
?
8

P.048 International MAGNIMS-CMSC-NAIMS consensus recommenda..:

Traboulsee, A ; Wattjes, M ; Ciccarelli, O...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  48 (2021)  s3 - p. S32-S33 , 2021
 
?
11

Predicting clinical progression in multiple sclerosis after..:

Dekker, I. ; Eijlers, A. J. C. ; Popescu, V....
European Journal of Neurology.  26 (2019)  6 - p. 893-902 , 2019
 
?
14

Inter-observer variation of hippocampus delineation in hipp..:

Bartel, F. ; van Herk, M. ; Vrenken, H....
Clinical and Translational Oncology.  21 (2018)  2 - p. 178-186 , 2018
 
?
15

PO-0748: Inter-observer delineation variation and dose to h..:

Bartel, F. ; Van Herk, M. ; Vrenken, H....
Radiotherapy and Oncology.  127 (2018)  - p. S384-S385 , 2018
 
1-15